DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bray GL, Gomperts ED, Courter S. et al.
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
Blood 1994;
83: 2428-2435.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.